SYNEXUS

Serial Number 97516475
603

Registration Progress

Application Filed
Jul 22, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

SYNEXUS

Basic Information

Serial Number
97516475
Filing Date
July 22, 2022
Abandonment Date
July 28, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
603
Status Date
Jul 28, 2025
Classes
042

Rights Holder

Synexus Clinical Research US, Inc.

03
Address
929 North Front Street
Wilmington, NC 28401

Ownership History

Synexus Clinical Research US, Inc.

Original Applicant
03
Wilmington, NC

Legal Representation

Attorney
KENYA WILLIAMS

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
Jul 28, 2025 MAB3 E ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL Loading...
Jul 28, 2025 EXPT T EXPARTE APPEAL TERMINATED Loading...
Jul 28, 2025 ABN3 O ABANDONMENT - AFTER EX PARTE APPEAL Loading...
Jun 16, 2025 EXFB T EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF Loading...
Dec 5, 2024 GECD O ACTION DENYING REQ FOR RECON E-MAILED Loading...
Dec 5, 2024 GEA1 O NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED Loading...
Dec 5, 2024 CNCF S ACTION CONTINUING FINAL - COMPLETED Loading...
Oct 24, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Oct 24, 2024 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Oct 24, 2024 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Oct 24, 2024 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Jul 24, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jul 24, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Apr 24, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Apr 24, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Apr 24, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Mar 29, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 29, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 29, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 27, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Dec 27, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Sep 29, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 29, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 29, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 25, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 24, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 24, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 25, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 25, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 25, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 9, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 27, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Clinical, chemical and medical research services in the field of pharmaceutical drugs, medical devices and clinical trials; scientific, clinical and industrial research and analysis services in the field of pharmaceutical drugs, medical devices and clinical trials; Medical and scientific research, namely, conducting clinical trials for others

Classification

International Classes
042